Tag: Association of the British Pharmaceutical Industry
Russell Abberley named Acting ABPI President as Susan Rienow becomes Pfizer CMO
As Acting ABPI President, he will focus on improving the UK’s international competitiveness in research, development, and the launch of innovative medicines
Russell Abberley, General...
£400 million VPAG investment programme launched to boost UK’s clinical trials
This new investment programme will lead to the creation of 18 new clinical trials hubs across UK to accelerate research
The UK government has announced...
NHS must prepare for future advanced therapies, says ABPI report
ABPI report recommends NHS to update its payment models for future advanced therapies
A new report from the Association of the British Pharmaceutical Industry (ABPI)...
ABPI urges A-level students to consider careers in pharmaceutical industry
Recent ABPI research reveals that Generation-Z is increasingly attracted to the pharmaceutical industry, largely driven by competitive salaries
Now that A-Level results have been announced,...
UK life sciences failing to reach its potential despite high R&D investment, new report reveals
Wes Streeting recently announced his plans to bolster the economy through the life sciences sector
“The UK remains genuinely world-leading for life sciences in...
ABPI outlines top priorities for Labour’s first 100 days in office
ABPI calls on Labour to urgently appoint a new Chair and Chief Executive to the Medicines and Healthcare products Regulatory Agency (MHRA)
The Association of...
